Q
uniQure NV D
D
QURE
51.050
USD
3.54
(7.45%)
مغلق
حجم التداول
114,010
الربح لكل سهم
-4
العائد الربحي
-
P/E
-13
حجم السوق
3,541,155,333
العنوان: uniQure NV
القطاع: الرعاية الصحية
الصناعة: Biotechnology
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.